chrisvoncsefalvay/vaers-outcomes huggingface dataset:
heart palpitation - ongoing. This is second shot, and the first shot in January heart palpitation lasted for 2 months - did not think about adverse effect of the vaccine until the heart palpitation returns again after the second shot. Also have diziness, and fatigure symptoms, but the worst is frequent heart palpitation.
ongoing left arm pain. No neck symptoms. Pain radiates to forearm. No numbness. No weakness.  Last advil was last night.
12 1/2 x 8 cm area of erythematous and redness to (R) deltoid. Onset 2/17/11, mother gave oral BENADRYL, TYLENOL, and applied cold compress.
A nurse reported the occurrence of an age unspecified female who did not respond to a hep B vaccine series (unk manuf) for prophylaxis. The subject had no relevant medical history, concurrent conditions or concurrent medications specified. On an unspecified date, "several years ago," the subject reported she had completed a hep B vaccine series. On an unspecified date, a titer was drawn which revealed negative antibodies. Comment: This case is considered non-reportable as an adverse event has not been reported.
Chills, sweats, fever, aches pains, fatigue for approximately 24 hrs.  Then fatigue for an additional 24 hours.
Information has been received from a physician concerning a 76 year old white female who was vaccinated SC in the right deltoid on 10-Aug-2007 with a first dose of Zostavax (Lot #656858/0356U).  The day after being vaccinated with Zostavax, the patient developed an elevated blood pressure of 175/90.  The patient's blood pressure returned to normal the next day and the patient recovered.  The patient sought medical attention.  Follow up information from the physician indicated that the patient experienced a severe elevation of blood pressure up to 178/104, 24 hours after vaccination.  This was confirmed with multiple blood pressure readings.  There was no prior history of blood pressures this high.  There was no illness at the time of vaccination.  The blood pressure resolved on its own.  The patient was asymptomatic the whole time.  On 13-Aug-2007 the patient recovered.  No further information was provided.  There was no product quality complaint involved.  Additional information is not expected. This is in follow-up to report (s) previously submitted on 12/21/2007. Information has been received from a physician concerning a 76 year old female with "blood pressure" who was vaccinated SC in the right deltoid on 10-AUG-2007 with a first dose of ZOSTAVAX vaccine (Merck) (Lot#656858/0356U). Concomitant medication included a blood pressure pill (therapy unspecified), one pill a day. The day after being vaccinated with ZOSTAVAX vaccine (Merck), the patient developed an elevated blood pressure of 175/90. The patient's blood pressure returned to normal the next day and the patient recovered. The patient sought medical attention. Follow up information from the physician indicated that the patient experienced a severe elevation of blood pressure up tp 178/104, 24 hours after vaccination. This was confirmed with multiple blood pressure readings. There was no prior history of blood pressure this high. There was no illness at the time of vaccination. The bood pressure resolved on its own. The patient was asymptomatic the whole time. On 13-AUG-2007 the patient recovered. No further information was provided. There was no product quality complaint involved. Follow up information from the consumer indicated that her blood pressure the day after the vaccination was 203/100. It was not indicated who obtained that reading. He reported that she has "not felt good since" she took the vaccine. Additional information is not expected.
Swollen lymph nodes, in the left side of my collaborne, appeared around 72 hours after my second dose, no pain, discovered by touch, around 1 cm of diameter
Patient developed a right facial droop the day after the vaccine and was diagnosed with Bell's Palsy.
Pt received Smallpox vaccination on 16AUG19 on the left upper arm and had first check up on 29AUG19 at Immunization. Pt had normal reaction on the vaccination site without any remarkable symptoms or adverse reactions at the check up. Pt started to have rash spreading out all aver left arm with itching from 7SEP19. Pt currently has a scab in normal process on the vaccination site and has 2 additional pruritic lesions sized less than 1cm on left upper arm distal to the vaccination site. Pt also has pruritic rash spreading out on both arms and both thighs. V/S with in normal range, no fever. Pt denied any other symptoms, chest congestion or pain and difficulty breathing. Pt denied any medical history related to skin condition or weaken immunity but there is Agency encounters documented in AUG and SEP2016 that  state he was prescribed oral antibiotics and doxycycline for acne vulgaris but had possible allergic reaction(or dermatitis) after using those medications. Denied CP/SOB/abd pain/fever/chills/N/V.  Completed Smallpox Screening sheet by Pt on 19AUG is not in the website. .
Started out as joint pain and heaviness. Progressed to extreme swelling in both hands. Progressed to upper arm pain. Treating with steroids. Treating with occupational therapy. So far refractory to steroids.
expired dose was administered to a patient; This non-serious case was reported by a physician via sales rep and described the occurrence of expired vaccine used in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19-JUL-2023, the patient received the 1st dose of Shingrix. On 19-JUL-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: expired dose was administered to a patient). The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 20 Jul 2023 The health care professional stated that an expired dose was administered to a patient, which led to expired vaccine used.  The reporter consented to follow up.
pt complained of severe itching & rash approx 3pm. visited ER @ 1am w/severe hives. treated w/benadryl. moderate swelling in hands. benadryl did not help
Patient received a booster dose 1 week after second dose. Patient did not have an adverse reaction nd will be followed.
Nausea, vomiting, diarrhea,  chills and fever, fainting and falling resulting in head injury
Information has been received from a physician as part of the Merck Pregnancy registry concerning a 25 year old white female patient with no past medical history who on 28-MAR-2007 was vaccinated with a first dose of GARDASIL (lot # 655126/0087U). A second dose was given on 29-MAR-2007 (lot # 0211U). There was no concomitant medication. The patient's LMP was 31-AUG-2007. The patient is now pregnant. She had a home pregnancy test and an ultrasound. She had an ultrasound on 24-OCT-2007 for a threatened miscarriage which was within limits and an MSAFP test on 02-JAN-2008 for a screening which was negative. On 07-NOV-2007 she started unspecified prenatal medications. There were no problems reported. Additional information has been requested.
Patient reported little "pimple like bumps" on arm where he received the injection 4-5  days post injection. He said it was not itchy or painful, but the bumps "kept growing"
Whole body hurting; Drenched in sweat; Fever; Nausea; Headache; Chills; Did not feel good,tired,Fatigue; Light headedness; Arm stiffness; Drowsy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headedness), HEADACHE (Headache), MUSCULOSKELETAL STIFFNESS (Arm stiffness), SOMNOLENCE (Drowsy) and FATIGUE (Did not feel good,tired,Fatigue) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced DIZZINESS (Light headedness), HEADACHE (Headache), MUSCULOSKELETAL STIFFNESS (Arm stiffness), SOMNOLENCE (Drowsy), FATIGUE (Did not feel good,tired,Fatigue) and CHILLS (Chills). On 16-Feb-2021, the patient experienced PYREXIA (Fever), NAUSEA (Nausea), PAIN (Whole body hurting) and HYPERHIDROSIS (Drenched in sweat). At the time of the report, DIZZINESS (Light headedness), HEADACHE (Headache), MUSCULOSKELETAL STIFFNESS (Arm stiffness), SOMNOLENCE (Drowsy), FATIGUE (Did not feel good,tired,Fatigue), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), PAIN (Whole body hurting) and HYPERHIDROSIS (Drenched in sweat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment for the events included Ibuprofen and Emergen C on daily basis. Concomitant product was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Headache, fatigue, fever, chills, are consistent with the product safety profile
Information has been received on 24-MAY-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 30-JAN-2008, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster also known as shingles and other complications. During 2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
SWOLLEN INJECTION SITE, FLU LIKE CONDITION, BODY ACHE, FEVER 102.0
This spontaneous report was received from a pharmacist and refers to a 27-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. In March 2016, the patient was vaccinated with the first dose of GARDASIL 9 intramuscularly (dose, lot # and expiration date were not provided) for prophylaxis. In May 2017, the patient was vaccinated with the second dose of GARDASIL 9 intramuscularly (dose, lot # and expiration date were not provided) for prophylaxis. No adverse effects were reported.
On 6-4-2022, I started having a runny nose and a mild cough. I started taking OTC daytime severe cold and flu symptom medication. On 6-5, I took a home Covid test and it was positive. I called my doctors office on 6-6 and he prescribed PAXLOVID. I am currently still taking this medication. I am feeling better today. I am reporting my breakthrough case of Covid.
Urticarial rash on face, neck, trunk. Pt came to ED and received prednisone 40 mg, diphenhydramine, famotidine. She will get 3 days of prednisone (40 mg/dose) total.
Patient felt dizzy, nauseous, couldn't lift arm, blacked out.  Seen by doctor on 09/15, got a heart test also had headache and quesy stomach.  Problems lasted for 7 days.
Swollen lymph nodes left side neck after 1st vaccine Swollen lymph nodes on right side neck   Continues to be enlarged & under going further testing as this has not been listed as a possible side effect.
I had the shot, in my arm and my arm has been hurting ever since where I got the shot, site of injection site pain; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot/ batch number unknown) via an unspecified route of administration on unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had the shot in arm and arm had been hurting ever since where patient got the shot, site of injection site pain. The patient stated that patient had the covid test on 23Jan2021 and result was unknown. The outcome of events was unknown.  Lot/Batch number has been requested. Follow-up attempts were completed. No further information was expected.
Patient received 1 dose of Pediarix and followed by 2 doses of Pentacel; 16 month old administered Kinrix; Kinrix by mistake as a 4th dose of DTaP; Kinrix given by mistake instead of Pentacel; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 16-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis, dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis and PENTACEL for prophylaxis.   On 28th October 2022, the patient received the 4th dose of Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, the patient received the 1st dose of Pediarix, Pediarix Pre-Filled Syringe Device and the 2nd dose of PENTACEL. On 28th October 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device and not applicable after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and wrong vaccine administered. On an unknown date, the patient experienced interchange of vaccine products. On an unknown date, the outcome of the inappropriate age at vaccine administration, inappropriate schedule of vaccine administered, wrong vaccine administered and interchange of vaccine products were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-OCT-2022 Reporter's Comment: The reporter was a medical assistant. The reporter reported that the patient received Kinrix vaccine by mistakenly at the age of 16 months who was supposed to received Pentacel. The reporter stated that the Kinrix vaccine was given as 4th dose of DTaP and IPV schedule. The reporter reported that the patient received 1st dose of Pediarix vaccine and the 2nd and 3rd dose of Pentacel vaccine before the Kinrix vaccine. The reporter did not consent to follow up. Additional supportive information: The patient received Kinirix who was younger than the indicated age which led to inappropriate age at vaccine administration. The patient received Kinirix received as 4th dose of DTap Series which led to  Inappropriate schedule of vaccine administered. The patient was administered with Pentacel vaccine after Pediarix , which led to interchange of vaccine products. The reporter reported that, they were intending to administered Pentacel and inadvertently administered Kinrix instead of Pentacel, which led to wrong vaccine administered.
Following GARDASIL vac. C/O weakness - syncope, vomiting, diarrhea, nausea, abd pain. Symptoms last 4 days.
Onset 1 day after vaccination C/O peeling "like my skin is crawling" "antsy" "arms weak" - states symptoms are "from the waist up".
During a flu clinic on location at the patient's residence, this patient who is 61 years old was given a Fluad vaccine approved for age 65+ only. Upon discovery, I attempted to contact the patient with no answer. I contacted the patient's PCP office and was able to notify someone of the occurrence.
Headache had not totally left at all, at the time of the report her headache was still severe on the right side over her eye; Fever; Chills; Aching all over/ soreness; mild symptoms of soreness and redness; she started a rash last night, it was like she had measles; a fine red rash all over legs, arms and trunk and on even on chest; had no appetite just feeling yucky; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302, expiration date: 31May2021), via unspecified route of administration on 15Jan2021 at single dose for COVID-19 immunisation. The relevant medical history included compromised immune system. Concomitant medications were not reported. The patient received first Covid on the 15Jan2021 and had mild symptoms of soreness and redness two days and then on the third day she started getting the headache and running a 99.4 fever an then on the fourth day she was running a fever 101.8, chills, aching all over, that fever had continued in the evening since then, went up to 102 was the highest count but its mostly to 100.8 to 101.8 since then and the headache had not totally left at all, at the time of the report her headache was still severe on the right side over her eye, she started a rash last night, it was like she had measles, a fine red rash all over legs, arms and trunk and on even on chest, she had no appetite just feeling yucky. The outcome of the events was unknown.
This spontaneous report was received from a physician via company representatives, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 30-APR-2014, the patient was vaccinated with an unspecified improperly stored dose of PNEUMOVAX 23 "10 Single dose 0.5mLVls 10SDV" with lot number J009689 and expiration date of 29-JAN-2015 (route of administration and anatomical location were not reported). On unspecified dates, the PNEUMOVAX 23 had four temperature excursions of 32 Fahrenheit (F) Degrees (0 Celsius) for 152 hours, 31 Fahrenheit (F) Degrees (-0.555555556 Celsius) for 32 hours, 33 Fahrenheit (F) Degrees (0.555555556 Celsius) for 200 hours, and 34 Fahrenheit (F) Degrees (1.111111111 Celsius) for 40 hours (lowest recorded temperatures). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported nor was product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
Mother inquired about giving  pt the polio vaccine along with other vaccines due at 15 month well child check up (Dtap and PedvaxHIB), Mother agreed to Kinrix vaccine (Dtap and Polio), vaccine was administered, when I went to chart vaccine I found out that Kinrix is for ages 4-6 years,  pt was monitored in office for 15 min after vaccine was administered, pt had no adverse effects at that time
Information has been received from an anonymous nurse concerning a male patient who on an unspecified date, was vaccinated with a first dose of ZOSTAVAX (Oka/Merck) (lot no. not reported) because it was a required vaccine for citizenship. The vaccine was not given by a physician but someone else. On an unspecified date, the patient passed away. An autopsy was being done at that time. The patient passed away was considered to be immediately life-threatening and disabling by the reporter. Additional information has been requested.
Patient experienced fever and chills x 36 hours.  In addition, patient reported disabling fatigue for the same period.  "Symptoms were way worse than COVID-19 itself when I had it."  Patient self-administered supportive treatment (e.g. "analgesics and supportive treatment").
Diarrhea for the past 4 days; headache; fatigue; dizziness; irritation; This is a spontaneous report received from a contactable consumer (Patient). A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 03Mar2021 08:00 as a single for covid-19 immunization. The patient's medical history and concomitant medication were not reported. The patient had no other vaccine in 4 weeks. The patient had no Covid prior vaccination nor tested post vaccination. On 04Mar2021 at 17:00, The patient experienced diarrhea (for the past 4 days),  headache, fatigue, dizziness and irritation (skin irritation). The patient had not received treatment for adverse events. The outcome was recovering for all the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
little bit of a sore arm/like I've had on the other Pfizer shots; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69-year-old male patient received BNT162b2 (BNT162B2), on 07Mar2021 as dose 2, single (Lot number: EL9262) at the age of 69 years intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Blood Pressure" (unspecified if ongoing); "Urine Disorder" (unspecified if ongoing). Concomitant medication(s) included: SERTRALINE. Vaccination history included: BNT162b2 (Dose 1, Route of Administration: intramuscular. , Batch/Lot number: EL9269), administration date: 13Feb2021, when the patient was 69-year-old, for Covid-19 immunization, reaction(s): "little bit of a sore arm/like I've had on the other Pfizer shots". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovering", described as "little bit of a sore arm/like I've had on the other Pfizer shots". Therapeutic measures were taken as a result of pain in extremity.  Additional information: The report was not related to a study or programme. He took his regular medications, like taking a blood pressure pill and a tablet for urinating, and he took Sertraline. He doesn't feel those are relevant, he has been taking all of them for 4-5 years and didn't have neck spasms.  The patient had a little bit of a sore arm, like he had on the other Pfizer shots, but nothing major. The patient stated vaccine was not administered at military facility. When he had a sore arm, he took some Tylenol and Ibuprofen, which was 500 mg for Tylenol, which he took a couple of times as needed. For the Ibuprofen dose would have been 200mg, which he took the same as the Tylenol, a couple of times as needed. Ibuprofen was taken at same time as Tylenol. His sore arm got better. The report was considered as non-serious by the reporter.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201348782 same patient, different vaccine dose number/event;